Joschua Friedel

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Toll Like Receptor

Artificial Intelligence

Anti Inflammatory

Top Venues

EMBO molecular medicine

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Tim J Schäufele, Anja Kolbinger, Joschua Friedel, Robert Gurke, Gerd Geisslinger, Andreas Weigert, Sandra Pierre, Klaus Scholich
Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids. British journal of pharmacology (2023)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine 15 (2) (2022)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine (2022)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine 15 (2) (2022)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine 15 (2) (2022)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine 15 (2) (2022)
Anja Kolbinger, Tim J Schäufele, Hanna Steigerwald, Joschua Friedel, Sandra Pierre, Gerd Geisslinger, Klaus Scholich
Eosinophil-derived IL-4 is necessary to establish the inflammatory structure in innate inflammation. EMBO molecular medicine 15 (2) (2022)